Xperi Inc has a consensus price target of $19.25 based on the ratings of 13 analysis. The 3 most-recent analyst ratings were released by BWS Financial, Rosenblatt, and Rosenblatt on May 9, 2024, March 1, 2024, and December 13, 2023, respectively. With an average price target of $20 between BWS Financial, Rosenblatt, and Rosenblatt, there's an implied 156.41% upside for Xperi Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/09/2024 | Buy Now | 284.62% | BWS Financial | Hamed Khorsand | $30 → $30 | Maintains | Top Pick | Get Alert |
03/01/2024 | Buy Now | 92.31% | Rosenblatt | Steven Frankel | → $15 | Reiterates | Buy → Buy | Get Alert |
12/13/2023 | Buy Now | 92.31% | Rosenblatt | Steven Frankel | → $15 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 92.31% | Rosenblatt | Steven Frankel | → $15 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | Buy Now | 92.31% | Rosenblatt | Steven Frankel | → $15 | Reiterates | Buy → Buy | Get Alert |
06/13/2023 | Buy Now | 92.31% | Rosenblatt | Steven Frankel | → $15 | Initiates | → Buy | Get Alert |
02/22/2023 | Buy Now | 143.59% | Maxim Group | Matthew Galinko | $23 → $19 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 66.67% | Stephens & Co. | Nicholas Zangler | → $13 | Reiterates | → Equal-Weight | Get Alert |
10/11/2022 | Buy Now | 194.87% | Maxim Group | Matthew Galinko | → $23 | Initiates | → Buy | Get Alert |
10/06/2022 | Buy Now | 284.62% | BWS Financial | Hamed Khorsand | → $30 | Initiates | → Top Pick | Get Alert |
08/02/2022 | Buy Now | 143.59% | Stephens & Co. | Nicholas Zangler | → $19 | Initiates | → Equal-Weight | Get Alert |
01/03/2022 | Buy Now | — | BWS Financial | Hamed Khorsand | — | Upgrade | Buy → Top Pick | Get Alert |
08/19/2021 | Buy Now | 297.44% | Maxim Group | Matthew Galinko | — | Initiates | → Buy | Get Alert |
The latest price target for Xperi (NYSE:XPER) was reported by BWS Financial on May 9, 2024. The analyst firm set a price target for $30.00 expecting XPER to rise to within 12 months (a possible 284.62% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Xperi (NYSE:XPER) was provided by BWS Financial, and Xperi maintained their top pick rating.
The last upgrade for Xperi Inc happened on January 3, 2022 when BWS Financial raised their price target to N/A. BWS Financial previously had a buy for Xperi Inc.
There is no last downgrade for Xperi.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xperi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xperi was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
While ratings are subjective and will change, the latest Xperi (XPER) rating was a maintained with a price target of $30.00 to $30.00. The current price Xperi (XPER) is trading at is $7.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.